⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 10, 2024World Journal of PsychiatryOpen Access

Shugan Jieyu capsule effects on peripheral blood micro-124, micro-132, and brain-derived neurotrophic factor in patients with mild to moderate depression

Xian Zhang Yang Liu Hua-Fei Tang Feng Jiang Chun‐Liang Chen Tingting Wang Hui-Zhong Gu Qiang Zhao Rui Ma

View Full Paper

Ask AI

Bookmark

Share

Abstract

To assess the effectiveness of Shugan Jieyu capsules on peripheral blood miR-124, miR-132, and brain-derived neurotrophic factor (BDNF) levels in patients with mild to moderate depression following coronary artery intervention [percutaneous coronary intervention (PCI)] for coronary heart disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e58eceb6db64358752a077 https://doi.org/10.5498/wjp.v14.i9.1354

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Meta-analysis of Shugan Jieyu Capsule for depression in patients with coronary heart diseasemeta-analysis · 2023 · 5 citations
2Efficacy and safety of Shugan Jieyu Capsule in the treatment of depressive state after acute coronary syndrome: study protocol for a multicenter randomized controlled trialother · 2025
3285. A MULTICENTER CLINICAL TRIAL OF SHUGANJIEYU CAPSULES COMBINED WITH FLUOXETINE IN THE TREATMENT OF DEPRESSION2025
4Efficacy and safety of Shugan Jieyu capsule in the treatment of essential hypertension with insomnia, anxiety or depressionsystematic_review · 2021 · 11 citations
5Efficacy and safety of the Shugan Jieyu capsule as a complementary treatment for functional dyspepsia: A systematic review and meta-analysis2025 · 1 citations

More related papers

Brain network predictors of changes in symptoms and serum BDNF following antidepressant treatment with escitalopram and Yueju Pill in major depressive disorder: a randomised, double-blind, placebo-controlled pilot study2025
["Shugan Tiaoshen" needling regulates lipid oxidative stress and inhibits ferroptosis of prefrontal neurons to improve post-stroke depression].2025
Transcriptomic analysis reveals the key role of inflammatory and immune signaling in the anti-perimenopausal depression effects of Bushen Shugan Huayu decoction2025

More from World Journal of Psychiatry

Artificial intelligence and major depression: Toward mechanistic and clinically actionable modelsTue,
Construction and validation of a predictive model for the risk of emergence delirium in older adult patientsThu,